(Q43525505)

24 November 2017

Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cells (English)

1 reference

24 November 2017

1 reference

1 reference

2

1 reference

24 November 2017

Benbrik E

1

1 reference

24 November 2017

Bonavaud S

3

1 reference

24 November 2017

Ammi-Saïd M

4

1 reference

24 November 2017

Frisdal E

5

1 reference

24 November 2017

Rey C

6

1 reference

24 November 2017

Gherardi R

7

1 reference

24 November 2017

Barlovatz-Meimon G

8

1 reference

24 November 2017

1 July 1997

1 reference

Journal of the Neurological Sciences

24 November 2017

1 reference

24 November 2017

149

1 reference

24 November 2017

1

1 reference

24 November 2017

19-25

1 reference

Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

2',3'-dideoxycytidine (ddC) toxic neuropathy: a study of 52 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Partial cytochrome c oxidase deficiency and cytoplasmic bodies in patients with zidovudine myopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Cytochrome c oxidase reaction improves histopathological assessment of zidovudine myopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Determination of the blood lactate:pyruvate ratio as a noninvasive test for the diagnosis of zidovudine myopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Myopathy and HIV infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Muscle involvement in human immunodeficiency virus-infected patients is associated with marked selenium deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

A microtiter plate assay for cytochrome c oxidase in permeabilized whole cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Mitochondrial myopathy caused by long-term zidovudine therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Zidovudine-induced mitochondrial myopathy is associated with muscle carnitine deficiency and lipid storage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Human myotube differentiation in vitro in different culture conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Effects of 2',3'-dideoxynucleosides on proliferation and differentiation of human pluripotent progenitors in liquid culture and their effects on mitochondrial DNA synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Schwann cell mitochondrial alterations in peripheral nerves of rabbits treated with 2',3'-dideoxycytidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Human immunodeficiency virus type 1 infection and myopathy: clinical relevance of zidovudine therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Preparation and properties of NADH: ubiquinone oxidoreductase (complexI), EC 1.6.5.3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Massive conversion of guanosine to 8-hydroxy-guanosine in mouse liver mitochondrial DNA by administration of azidothymidine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Major growth reduction and minor decrease in mitochondrial enzyme activity in cultured human muscle cells after exposure to zidovudine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Cellular targets of 3'-azido-3'-deoxythymidine: an early (non-delayed) effect on oxidative phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Satellite cell myogenesis is highly stimulated by the kinase inhibitor iso-H7: comparison with HA1004 and staurosporine effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Zidovudine induces molecular, biochemical, and ultrastructural changes in rat skeletal muscle mitochondria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Mitochondrial toxicity of antiviral drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Clinical pharmacology of 3'-azido-2',3'-dideoxythymidine (zidovudine) and related dideoxynucleosides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

Long-term toxicity/activity profile of 2',3'-dideoxyinosine in AIDS or AIDS-related complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2897%2905376-8

10.1016/S0022-510X(97)05376-8

7 January 2021

Identifiers

DOI

1 reference

24 November 2017

1 reference